Laboratory Parameters and Glucocorticoid Dosages at Baseline and During Follow-up
Variable . | At Baseline (n = 48a) . | Mean During Follow up (n = 48) . |
---|---|---|
ESR (mm) | 40 (18–64) | 20 (13–37) |
CRP (mg/L) | 36 (12–71) (n = 33) | 20 (9–38) (n = 45) |
Platelets (G/L) | 422 (324–584) (n = 34) | 353 (291–444) (n = 47) |
Hemoglobin (g/dL) | 11.0 (10.0–11.8) (n = 34) | 11.7 (10.7–12.5) (n = 47) |
Prednisone equivalent (mg/kg per d) | 0.4 (0.2–0.5)b | 0.2 (0.1–0.4) |
IGF1 (ng/mL) | 168 (114–223) (n = 46) | 493 (353–585) |
IGF1 (SDS)c | −1.2 (−2.4 to 0.1) (n = 38) | 1.0 (0.1−2.1) |
Variable . | At Baseline (n = 48a) . | Mean During Follow up (n = 48) . |
---|---|---|
ESR (mm) | 40 (18–64) | 20 (13–37) |
CRP (mg/L) | 36 (12–71) (n = 33) | 20 (9–38) (n = 45) |
Platelets (G/L) | 422 (324–584) (n = 34) | 353 (291–444) (n = 47) |
Hemoglobin (g/dL) | 11.0 (10.0–11.8) (n = 34) | 11.7 (10.7–12.5) (n = 47) |
Prednisone equivalent (mg/kg per d) | 0.4 (0.2–0.5)b | 0.2 (0.1–0.4) |
IGF1 (ng/mL) | 168 (114–223) (n = 46) | 493 (353–585) |
IGF1 (SDS)c | −1.2 (−2.4 to 0.1) (n = 38) | 1.0 (0.1−2.1) |
Laboratory Parameters and Glucocorticoid Dosages at Baseline and During Follow-up
Variable . | At Baseline (n = 48a) . | Mean During Follow up (n = 48) . |
---|---|---|
ESR (mm) | 40 (18–64) | 20 (13–37) |
CRP (mg/L) | 36 (12–71) (n = 33) | 20 (9–38) (n = 45) |
Platelets (G/L) | 422 (324–584) (n = 34) | 353 (291–444) (n = 47) |
Hemoglobin (g/dL) | 11.0 (10.0–11.8) (n = 34) | 11.7 (10.7–12.5) (n = 47) |
Prednisone equivalent (mg/kg per d) | 0.4 (0.2–0.5)b | 0.2 (0.1–0.4) |
IGF1 (ng/mL) | 168 (114–223) (n = 46) | 493 (353–585) |
IGF1 (SDS)c | −1.2 (−2.4 to 0.1) (n = 38) | 1.0 (0.1−2.1) |
Variable . | At Baseline (n = 48a) . | Mean During Follow up (n = 48) . |
---|---|---|
ESR (mm) | 40 (18–64) | 20 (13–37) |
CRP (mg/L) | 36 (12–71) (n = 33) | 20 (9–38) (n = 45) |
Platelets (G/L) | 422 (324–584) (n = 34) | 353 (291–444) (n = 47) |
Hemoglobin (g/dL) | 11.0 (10.0–11.8) (n = 34) | 11.7 (10.7–12.5) (n = 47) |
Prednisone equivalent (mg/kg per d) | 0.4 (0.2–0.5)b | 0.2 (0.1–0.4) |
IGF1 (ng/mL) | 168 (114–223) (n = 46) | 493 (353–585) |
IGF1 (SDS)c | −1.2 (−2.4 to 0.1) (n = 38) | 1.0 (0.1−2.1) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.